It’s a lie
Adagio Therapeutics downgraded to hold from buy at Stifel, price target slashed to $9 from $50
MW Adagio Therapeutics downgraded to hold from buy at Stifel, price target slashed to $9 from $50
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
点赞
举报
登录后可参与评论
暂无评论